Clarification sought from Cipla

23 Mar 2017 Evaluate

The Exchange has sought clarification from Cipla with respect to news article appearing on ET NOW on March 23, 2017 titled ‘USFDA issued import alert on Ciplas Tadalafil drug made at Bhagwanpur unit.’

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1351.85 4.20 (0.31%)
02-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.70
Dr. Reddys Lab 1294.65
Cipla 1351.85
Zydus Lifesciences 906.85
Lupin 2311.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×